Inactive Instrument

Calendar Galapagos NV Euronext Bruxelles

Stocks

GLPG

BE0003818359

Biotechnology & Medical Research

End-of-day quote Euronext Bruxelles
-	-

Sep. 23	Lakefront Biotherapeutics' Gamgertamig Has Meaningful Opportunity in Rare Autoimmune Diseases, RBC Says	MT
Sep. 23	RBC Upgrades Lakefront Biotherapeutics to Outperform From Sector Perform, Adds Speculative Risk, Raises Price Target to $45 From $26	MT

Upcoming events on Galapagos NV

2026-11-11	Earnings release - Q3 2026
2026-11-12	Earnings presentation

Past events on Galapagos NV

2026-08-10	Earnings presentation
2026-08-10	Earnings release - Q2 2026
2026-05-07	Earnings presentation	08:00 am
2026-05-06	Earnings release - Q1 2026
2026-04-28	Annual General Meeting	08:00 am
2026-04-28	Extraordinary General Meeting	09:00 am
2026-02-24	Earnings presentation	08:00 am
2026-02-23	Earnings release - Annual 2025
2025-11-06	Earnings presentation	08:00 am
2025-11-05	Earnings release - Q3 2025

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million EUR	Released Forecast Spread	784 550 42.49%	276 309 -10.82%	1 112 280 297.2%	117	41,9	29,5
EBITDA Million EUR	Released Forecast Spread	0,00 -213 -	-153 -57,1 -167.99%	351 -364 196.41%	-132	-202	-284
EBIT Million EUR	Released Forecast Spread	129 -148 187.11%	-188 -133 -41.58%	295 -383 177.08%	-172	-222	-286
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	5,63 8,44 -33.34%	-3,09 -48,1 93.59%	301 -395 176.13%	-46,2	-194	-256
Net income Million EUR	Released Forecast Spread	212 -52,8 500.82%	74,1 -10,8 784.74%	321 -308 204.19%	-40,7	-213	-316
EPS EUR	Released Forecast Spread	3,21 -1,58 302.72%	1,12 -0,28 497.36%	4,87 -3,29 248.17%	-1,89	-4,66	-7,54
Announcement Date		22/02/24	12/02/25	23/02/26	-

Quarterly results

Fiscal Period	June	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2
Net sales Million EUR	Released Forecast Spread	75,5 69,9 8%	75,0 68,9 8.87%	65,3 70,5 -7.43%	71,2 69,1 3.01%	901 71,3 1162.61%	6,48 24,9 -73.97%	12,1 6,13 97.55%	41,2	107	6,95	6,95	6,95	6,95	7,01	7,01
EBITDA Million EUR	Released Forecast Spread	5,24							-30,0	6,05
EBIT Million EUR	Released Forecast Spread	-62,7 -33,7 -86.25%	-159 -35,6 -345.53%	-57,0 -33,5 -70.09%	-246 -33,5 -635.46%	757 -21,4 3642.73%	-63,7 -96,1 33.7%	-43,5 -794 94.52%	-32,6	-14,8	-44,6	-44,7	-45,0	-45,2	-46,5	-46,7
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	19,0 -37,9 150.18%	-156 -15,6 -899.75%	-104 -13,6 -667.4%	-221 -27,7 -698.6%	783 -9,27 8545.24%	14,0 -76,2 118.31%	2,01 -763 100.26%	-9,60	-52,4	-32,3	-32,7	-33,5	-34,1	-34,8	-35,3
Net income Million EUR	Released Forecast Spread	25,3 -50,3 150.36%	-153 -13,7 -1022.64%	-106 -13,6 -677.13%	-202 -19,6 -931.38%	782 85,3 816.5%	14,5 -73,1 119.83%	2,11 -758 100.28%	-7,10	-50,2	-27,3	-27,7	-28,5	-29,1	-29,8	-30,3
EPS EUR	Released Forecast Spread	0,38 -2,33 116.31%	-2,33 -0,19 -1097.2%	-1,60 -0,09 -1719.01%	-3,07 -0,23 -1236.29%	11,9 5,54 114.64%	0,22 -0,51 143.55%	0,03	-0,43	-1,70
Announcement Date		12/02/25	23/04/25	23/07/25	05/11/25	23/02/26	06/05/26	10/08/26	-	-	-	-	-	-	-	-

Upcoming sector events for Galapagos NV

2026-10-06	BASILEA PHARMACEUTICA AG	Information meeting
2026-10-06	OMNIAB, INC.	Analyst/Investor Day	11:00 am
2026-10-12	LONZA GROUP AG	Analyst/Investor Day
2026-10-12	BIDE PHARMATECH CO., LTD.	Extraordinary General Meeting	10:00 pm
2026-10-13	GEMPHARMATECH CO., LTD.	Earnings presentation	10:00 pm
2026-10-14	LONZA GROUP AG	Analyst/Investor Day	12:00 pm
2026-10-18	GEMPHARMATECH CO., LTD.	Extraordinary General Meeting	10:00 pm
2026-10-20	ARCUS BIOSCIENCES, INC.	Information meeting	08:30 am
2026-10-20	4D MOLECULAR THERAPEUTICS, INC.	Analyst/Investor Day
2026-10-21	MEDPACE HOLDINGS, INC.	Earnings release - Q3 2026

Past sector events for Galapagos NV

2026-10-01	MONTE ROSA THERAPEUTICS, INC.	Information meeting	08:00 am
2026-09-30	JADE BIOSCIENCES, INC.	Information meeting	08:30 am
2026-09-29	ADLAI NORTYE GROUP LTD.	Extraordinary General Meeting	10:00 pm
2026-09-29	GENFIT	Earnings release - Q2 2026
2026-09-28	SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.	Extraordinary General Meeting	02:30 am
2026-09-28	R&G PHARMASTUDIES CO., LTD.	Extraordinary General Meeting	02:30 am
2026-09-24	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Analyst/Investor Day	09:00 am
2026-09-24	ACADIA PHARMACEUTICALS INC.	Information meeting	08:00 am
2026-09-23	BIO-TECHNE CORPORATION	Extraordinary General Meeting	09:00 am
2026-09-23	BIO-TECHNE CORPORATION	Présentation aux Actionnaires / Analystes	09:00 am

Stock markets for all

100% Free Registration

100% Free Registration